Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts.

Suda K, Tomizawa K, Mizuuchi H, Ito S, Kitahara H, Shimamatsu S, Kohno M, Yoshida T, Okamoto T, Maehara Y, Yatabe Y, Mitsudomi T.

Aging Dis. 2012 Dec;3(6):438-43. Epub 2012 Oct 23.

2.

Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer.

Lee JK, Park HS, Kim DW, Kulig K, Kim TM, Lee SH, Jeon YK, Chung DH, Heo DS, Kim WH, Bang YJ.

Cancer. 2012 Jul 15;118(14):3579-86. doi: 10.1002/cncr.26668. Epub 2011 Nov 15.

3.

Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?

Hsu LH, Chu NM, Liu CC, Tsai SY, You DL, Ko JS, Lu MC, Feng AC.

Lung Cancer. 2009 Nov;66(2):262-7. doi: 10.1016/j.lungcan.2009.01.020. Epub 2009 Mar 18.

PMID:
19299032
4.

EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer.

Wang Z, Zhang X, Bai H, Zhao J, Zhuo M, An T, Duan J, Yang L, Wu M, Wang S, Wang Y, Wu Y, Wang J.

Oncology. 2012;83(5):248-56. doi: 10.1159/000341381. Epub 2012 Sep 4.

PMID:
22964709
5.

Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma.

Paik JH, Choi CM, Kim H, Jang SJ, Choe G, Kim DK, Kim HJ, Yoon H, Lee CT, Jheon S, Choe JY, Chung JH.

Lung Cancer. 2012 Jun;76(3):403-9. doi: 10.1016/j.lungcan.2011.11.008. Epub 2011 Nov 30.

PMID:
22129856
6.

Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer.

Jeon YK, Sung SW, Chung JH, Park WS, Seo JW, Kim CW, Chung DH.

Lung Cancer. 2006 Dec;54(3):387-98. Epub 2006 Sep 29.

PMID:
17011067
7.

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.

Bae NC, Chae MH, Lee MH, Kim KM, Lee EB, Kim CH, Park TI, Han SB, Jheon S, Jung TH, Park JY.

Cancer Genet Cytogenet. 2007 Mar;173(2):107-13.

PMID:
17321325
8.

Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.

Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.

Clin Cancer Res. 2000 Oct;6(10):4073-81.

9.

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

Wong DW, Leung EL, So KK, Tam IY, Sihoe AD, Cheng LC, Ho KK, Au JS, Chung LP, Pik Wong M; University of Hong Kong Lung Cancer Study Group.

Cancer. 2009 Apr 15;115(8):1723-33. doi: 10.1002/cncr.24181.

10.

The elderly patient with surgically resected non-small cell lung cancer--a distinct situation?

Sterlacci W, Stockinger R, Schmid T, Bodner J, Hilbe W, Waldthaler C, Oberaigner W, Tzankov A, Fiegl M.

Exp Gerontol. 2012 Mar;47(3):237-42. doi: 10.1016/j.exger.2011.12.008. Epub 2011 Dec 29.

PMID:
22226625
11.

Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.

Chou TY, Chiu CH, Li LH, Hsiao CY, Tzen CY, Chang KT, Chen YM, Perng RP, Tsai SF, Tsai CM.

Clin Cancer Res. 2005 May 15;11(10):3750-7.

12.

Surgical results of stage I non-small cell lung cancer: comparison between elderly and younger patients.

Yamamoto K, Padilla Alarcón J, Calvo Medina V, García-Zarza A, Pastor Guillen J, Blasco Armengod E, París Romeu F.

Eur J Cardiothorac Surg. 2003 Jan;23(1):21-5.

PMID:
12493498
13.

EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer.

Wu M, Zhao J, Song SW, Zhuo M, Wang X, Bai H, Wang S, Yang L, An T, Zhang Y, Duan J, Wang Y, Guo Q, Liu X, Liu N, Wang J.

Lung Cancer. 2010 Mar;67(3):343-7. doi: 10.1016/j.lungcan.2009.04.011. Epub 2009 May 27.

PMID:
19477549
14.

Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.

Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.

Oncogene. 1998 May 14;16(19):2469-77.

15.

Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.

Sasaki H, Shimizu S, Okuda K, Kawano O, Yukiue H, Yano M, Fujii Y.

Lung Cancer. 2009 Jun;64(3):295-300. doi: 10.1016/j.lungcan.2008.10.005. Epub 2008 Dec 5.

PMID:
19058870
16.

[Role of EGFR mutation status in patients with stage III non-squamous non-small cell lung cancer treated with chemoradiotherapy].

Li F, Bai H, Li X, Wu M, Yu R, Shi A, Yin L, Wang J, Zhu G.

Zhongguo Fei Ai Za Zhi. 2011 Sep;14(9):715-8. doi: 10.3779/j.issn.1009-3419.2011.09.03. Chinese.

17.

Clinical outcomes of thoracic radiotherapy for locally advanced NSCLC with EGFR mutations or EML4-ALK rearrangement.

Hayashi H, Okamoto I, Kimura H, Sakai K, Nishimura Y, Nishio K, Nakagawa K.

Anticancer Res. 2012 Oct;32(10):4533-7.

PMID:
23060582
18.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.

19.

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, Fujisawa T, Feng Z, Roth JA, Herz J, Minna JD, Gazdar AF.

J Natl Cancer Inst. 2005 Mar 2;97(5):339-46.

PMID:
15741570
20.

An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.

Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43.

PMID:
16029805

Supplemental Content

Support Center